SCHEMBL528399

SCHEMBL528399

CCS(=O)(=O)N(Cc1ccc(NC(=O)c2ccc(OC)cc2)cc1)c1ccc(C)c(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.56
LMNA P02545 4/20 0.56
HTT P42858 2/20 0.52
NPC1 O15118 6/20 0.50
SMN1; SMN2 Q16637 6/20 0.50
RAB9A P51151 4/20 0.50
TP53 P04637 2/20 0.50
ALOX15 P16050 1/20 0.50
ALDH1A1 P00352 4/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
GAA P10253 2/20 0.49
HPGD P15428 2/20 0.49
KDM4E B2RXH2 3/20 0.49
CYP1A2 P05177 2/20 0.49
STAT3 P40763 1/20 0.48
RECQL P46063 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.47
GALR3 O60755 1/20 0.47
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL528800 0.91 MAPT (0.62) MAPTLMNAHTTNPC1SMN1; SMN2
SCHEMBL528007 0.91 MAPT (0.62) MAPTLMNAHTTNPC1SMN1; SMN2
SCHEMBL529259 0.90 MAPT (0.55) MAPTLMNAHTTNPC1SMN1; SMN2
SCHEMBL529579 0.89 MAPT (0.61) MAPTLMNAHTTNPC1SMN1; SMN2
SCHEMBL529426 0.89 LMNA (0.55) MAPTLMNAHTTSMN1; SMN2KMT2A
SCHEMBL528511 0.88 KMT2A (0.52) MAPTLMNAHTTNPC1SMN1; SMN2
SCHEMBL528823 0.88 MAPT (0.53) MAPTLMNAHTTNPC1SMN1; SMN2
SCHEMBL528087 0.88 KMT2A (0.55) MAPTLMNANPC1SMN1; SMN2RAB9A
SCHEMBL528901 0.87 MAPT (0.74) MAPTLMNAHTTSMN1; SMN2ALDH1A1
SCHEMBL528937 0.87 MAPT (0.47) MAPTLMNAHTTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012014127-A1 5-LIPOXYGENASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2012-02-02 WO disclosed